# Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3

> **NCT04820010** · — · COMPLETED · sponsor: **Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.** · enrollment: 20 (actual)

## Conditions studied

- Corneal Ulcer
- Corneal Perforation
- Corneal Epithelium Defect
- Neurotrophic Keratitis

## Interventions

- **DRUG:** Topical Insulin

## Key facts

- **NCT ID:** NCT04820010
- **Lead sponsor:** Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2020-11-01
- **Final completion:** 2020-11-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04820010

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04820010, "Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04820010. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*